Crisaborole and Atopic Dermatitis Skin Biomarkers: An Intrapatient Randomized Trial

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2019.06.047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Antimicrobial Peptides, Skin Infections, and Atopic Dermatitis

Seminars in Cutaneous Medicine and Surgery
DermatologyMedicineSurgery
2008English

A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Phase 1 Study of Crisaborole in Japanese Healthy Volunteers and Patients With Atopic Dermatitis

Journal of Dermatology
DermatologyMedicine
2019English

Clinical and Immunological Changes of Immunotherapy in Patients With Atopic Dermatitis: Randomized Controlled Trial

ISRN Allergy
2012English

453 GBR 830 Induces Progressive and Sustained Changes in Atopic Dermatitis Biomarkers in Patient Skin Lesions

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Role of the Skin Microbiome in Atopic Dermatitis

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Vaccinia Virus–specific Molecular Signature in Atopic Dermatitis Skin

Journal of Allergy and Clinical Immunology
AllergyImmunology
2010English

Effect of Tarcolimus on Skin Microbiome in Atopic Dermatitis

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Long-Term Safety of Crisaborole Ointment 2% in Children and Adults With Mild-To-Moderate Atopic Dermatitis

Pediatrics
Child HealthPediatricsPerinatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy